• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Friday, September 29, 2023
Comal County News Online
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
No Result
View All Result
Home News

Pfizer Oral COVID-19 Pill Gets U.S. Authorization For At-Home Use – Reuters

by NewsReporter
December 22, 2021
in News
pfizer-oral-covid-19-pill-gets-us.-authorization-for-at-home-use-–-reuters
Share on FacebookShare on Twitter

Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

Register now for FREE unlimited access to Reuters.com

Dec 22 (Reuters) – The U.S. on Wednesday authorized Pfizer Inc’s (PFE.N) oral antiviral COVID-19 pill for at-risk peopleaged 12 and above, making it the first at-home treatment for the coronavirus and a potentially important tool in the fight against the fast spreading Omicron variant.

Data from Pfizer’s clinical trial showed its antiviral regimen, Paxlovid, was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said. read more

“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,” Patrizia Cavazzoni, director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, said.

Register now for FREE unlimited access to Reuters.com

Pfizer said it was ready to start immediate delivery in the U.S. of the treatment – whose two drug regimen includes a new medicine and a second older antiviral called ritonavir – and raised its 2022 production projections to 120 million courses of treatment from 80 million.

The agency’s decision comes as the country combats a surge in COVID-19 cases driven by the Omicron variant, with U.S. President Joe Biden announcing plans for more federal vaccination and testing sites.

The U.S. government’s contract for 10 million courses of the Pfizer drug is priced at $530 per course.

The agency said it authorized the oral drug for emergency use for the treatment of mild-to-moderate disease in adults and pediatric patients 12 years of age and older, who are at high risk for progression to severe COVID-19.

The drug is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset, the agency said. The pills are meant to be taken every 12 hours for five days beginning shortly after the onset of symptoms.

The second drug, ritonavir, is known to have interactions with some other prescription medicines. Pfizer has said that should be manageable and suggested most patients would be able to lower the dose of their other medications while being treated for COVID-19.

Pfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval.

A rival pill from Merck & Co (MRK.N), which is under review by the FDA, has shown lower efficacy compared with Pfizer’s treatment. Merck’s drug, molnupiravir, reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.

Pfizer shares were up 2% at $60.18 in afternoon trading on Wednesday.

Register now for FREE unlimited access to Reuters.com

Reporting by Dania Nadeem and Ankur Banerjee in Bengaluru; Editing by Bill Berkrot and Nick Zieminski

Our Standards: The Thomson Reuters Trust Principles.

Related Posts

gearhead-enjoys-piecing-cars-back-together-|-community-alert-|-herald-zeitung.com-–-herald-zeitung

Gearhead Enjoys Piecing Cars Back Together | Community Alert | Herald-Zeitung.com – Herald Zeitung

by NewsReporter
April 14, 2022
0

“It doesn’t matter if you are 16, 22, 40, 82 or 90. Everybody loves a Ford Mustang.”That is just one of the many observations Doyle Marshall has made regarding Americans and their love of automobiles. Doyle knows a thing or two about cars. He serves as co-chair of the New...

Ukrainians Face New Hurdle At U.S. Border: No Dogs – The New York Times

by NewsReporter
April 14, 2022
0

Please enable JS and disable any ad blocker

perspective-|-here’s-how-the-us.-should-respond-to-any-russian-cyberattacks-–-the-washington-post

Perspective | Here’s How The U.S. Should Respond To Any Russian Cyberattacks – The Washington Post

by NewsReporter
April 14, 2022
0

Placeholder while article actions loadRussian cyberattacks may be coming. Last month, the White House issued its starkest warning yet that “evolving” intelligence indicates Moscow is planning major cyber operations against the United States in retaliation for the economic penalties that the country has imposed on Russia for its invasion of...

100-club-of-comal-county-honors-late-sheriff,-constable-remembered-for-their-long-time-service-–-herald-zeitung

100 Club Of Comal County Honors Late Sheriff, Constable Remembered For Their Long-Time Service – Herald Zeitung

by NewsReporter
April 13, 2022
0

End of watch for two late county lawmen was one of the most poignant highlights of the 100 Club of Comal County’s annual dinner, attended by hundreds Tuesday night at the New Braunfels Civic/Convention Center.Criminal District Attorney Jennifer Tharp paid homage to both legends whose long-time county service was celebrated...

Comal County News Online

© 2021 Comal County News Online

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Comal County News Online

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT